Literature DB >> 2467224

Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphé nucleus of the rat.

G A Higgins1, A J Bradbury, B J Jones, N R Oakley.   

Abstract

The behavioural and biochemical response to the 5-HT1-like receptor compounds, 5-carboxamidotryptamine (5-CT), 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), buspirone and ipsapirone and the GABA agonist, muscimol, injected into the dorsal raphé nucleus (DRN) are reported. All compounds increased social interaction under high light, unfamiliar conditions and increased punished responding in a Vogel conflict test. At doses ranging from 5-25 times greater than those which were effective in these anxiety models, muscimol, 5-CT and 8-OH-DPAT induced a marked hypothermia and a flattening of body posture. Buspirone, on the other hand, failed to induce a significant reduction in core temperature or produce a marked flattening of posture in all animals, even at doses 100 times those effective in anxiety models. Following injection of muscimol, 5-CT, 8-OH-DPAT and buspirone into the dorsal raphé nucleus, all tended to reduce the 5-HIAA:5-HT ratios in the frontal cortex, hippocampus and hypothalamus. These findings, together with available electrophysiological data suggest that these behavioural responses are a consequence of a depression of the firing of cells in the dorsal raphé nucleus, with a corresponding decrease in functional activity of 5-HT in the forebrain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2467224     DOI: 10.1016/0028-3908(88)90058-5

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  36 in total

1.  Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection.

Authors:  G A Higgins; B J Jones; N R Oakley
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists.

Authors:  G A Higgins; B J Jones; N R Oakley; M B Tyers
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 3.  5-HT1A partial agonists. What is their future?

Authors:  D A Glitz; R Pohl
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

4.  A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus.

Authors:  L E Gonzalez; S E File
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

5.  Exposure to an open-field arena increases c-Fos expression in a subpopulation of neurons in the dorsal raphe nucleus, including neurons projecting to the basolateral amygdaloid complex.

Authors:  M W Hale; A Hay-Schmidt; J D Mikkelsen; B Poulsen; J A Bouwknecht; A K Evans; C E Stamper; A Shekhar; C A Lowry
Journal:  Neuroscience       Date:  2008-10-04       Impact factor: 3.590

6.  Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat.

Authors:  K Yoshimoto; W J McBride
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

7.  Evidence for postsynaptic mediation of the hypothermic effect of 5-HT1A receptor activation.

Authors:  M T O'Connell; G S Sarna; G Curzon
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

8.  Adaptations in pre- and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats.

Authors:  Judith R Homberg; Sietse F De Boer; Halfdan S Raasø; Jocelien D A Olivier; Mark Verheul; Eric Ronken; Alexander R Cools; Bart A Ellenbroek; Anton N M Schoffelmeer; Louk J M J Vanderschuren; Taco J De Vries; Edwin Cuppen
Journal:  Psychopharmacology (Berl)       Date:  2008-06-27       Impact factor: 4.530

9.  Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice.

Authors:  L K Heisler; H M Chu; T J Brennan; J A Danao; P Bajwa; L H Parsons; L H Tecott
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

10.  Dihydroergotamine and its metabolite, 8'-hydroxy-dihydroergotamine, as 5-HT1A receptor agonists in the rat brain.

Authors:  N Hanoun; F Saurini; L Lanfumey; M Hamon; S Bourgoin
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.